Evidence map›Paper›PMID 28331336›Full record

ReviewOncoTargets and therapy2017

Fengying Zhang, Xijiang Wu, Jinming Niu, Xiufeng Kang, Liya Cheng, Yanchun Lv, Meimei Wu

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fengying ZhangOtorhinolaryngological Department, Wei Fang Traditional Chinese Hospital, Weifang, Shandong Province, China.
Xijiang WuOtorhinolaryngological Department, Shouguang Peoples Hospital, Shouguang, Shandong Province, China.
Jinming NiuOtorhinolaryngological Department, Wei Fang Traditional Chinese Hospital, Weifang, Shandong Province, China.
Xiufeng KangMedical insurance office, Shouguang Peoples Hospital, Shouguang, Shandong Province, China.
Liya ChengOtorhinolaryngological Department, Wei Fang Traditional Chinese Hospital, Weifang, Shandong Province, China.
Yanchun LvOtorhinolaryngological Department, Wei Fang Traditional Chinese Hospital, Weifang, Shandong Province, China.
Meimei WuOtorhinolaryngological Department, Wei Fang Traditional Chinese Hospital, Weifang, Shandong Province, China.
Weifang Chinese Medicine Hospital · CNShougang (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccumulating data have reported that

methodsPubmed, Embase, and China National Knowledge Infrastructure (CNKI) databases were searched for potential articles. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the relationship of GSTM1 polymorphism with the risks of NPC and LC.

resultsThirty-two eligible articles were included. Pooled outcome suggested the significant relationship of

conclusion

Indexed as

GSTM1LCNPCpolymorphism

Identifiers

PMID28331336
PMCPMC5348073
OpenAlexW2592982225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.